The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the ...

BioNTech's BNT324 aims to outpace rivals in cancer treatment with its unique bispecific antibody design. Read more here.

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $10.6 million in its first quarter. On a per-share basis, the Bay Harbor ...

Meanwhile, at STAT’s Breakthrough Summit West in San Francisco, former FDA Commissioner Robert Califf criticized RFK Jr.’s ...

A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.